EAACI Congress 2023
BackBiologicals in atopic dermatitis – real world evidence
Friday 09 Jun, 15:00 PM -
16:30 PM CEST
Hall Y 03+04
ORAL Session
15:00
Dupilumab Treatment Normalizes Skin Barrier Function and Symptoms in Children Aged 6 to 11 Years With Moderate-to-Severe Atopic Dermatitis
15:12
Efficacy and Safety of Dupilumab Treatment With Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years With Severe Atopic Dermatitis
15:24
Exploring Cascade of Comorbidities within Atopic Dermatitis Among a Korean National Population
15:36
Sequence of Improvement in Atopic Dermatitis Signs and Symptoms in Patients Aged 6 Months to 17 Years Treated With Dupilumab
15:48
Infantile atopic dermatitis and maternal-infant bonding: a mixed methods study
